Mizusawa Hidehiro
Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences.
Rinsho Shinkeigaku. 2010 Nov;50(11):797-802.
Human prion diseases are classified into 3 categories according to etiologies: idiopathic of unknown cause, acquired of infectious origin, and genetic by PRNP mutation. The surveillance committee have analyzed 2,494 cases and identified 1,402 as prion diseases. Most of them are idiopathic, namely sporadic CJD (77%) with less genetic and acquired prion diseases (17% and 5%, respectively). The number of patients identified by the surveillance committee in these years is about 120 which are less than the number of annual death of prion disease. The difference might be due to partly the fact our surveillance need the consent from patients' family and is not complete. The mean age at onset of prion disease is late 60s while the range is fairly wide. Brain MRIs and increase of CSF 14-3-3 and tau protein levels are very characteristic. Classical sporadic CJD could show completely normal T1WI with patchy high signals in the cerebral cortex and basal ganglia on DWI. In Japan, classical sporadic CJD (MM1) is most popular but there are some rare atypical subtypes. Among them, MM2-thalamic CJD is hardest to diagnose because it shows no high intensity signals on DWI, in addition to frequent absence of CSF and EEG characteristics. In this case, CBF decrease in the thalamus on SPECT is very helpful. Genetic prion diseases in Japan are quite distinct from those in Europe. V180I and M232R mutations are unique to Japan and show sporadic CJD phenotype. Dura graft-associated CJD (dCJD) are composed of 67% of classical sporadic CJD phenotype and 33% of atypical phenotype showing slower progression with amyloid plaques. Trace-back experiments suggested the PrP(sc) of the atypical dCJD was likely to be modified from infection of abnormal VV2 protein. Although there are some atypical forms of prion diseases as mentioned above, almost all prion cases could be diagnosed with EEG, MRI, genetic test, CSF test and SPECT. We also have some incidents in which brain surgery was done before the diagnosis of prion disease and many other patients were operated using the same operating instruments before their sterilization against prion disease had been done. The explanation of possibility of prion disease infection to the patients and their follow-up was started by the incident committee. It is very important for all the nations to cooperate with each other in order to overcome this intractable disease.
人类朊病毒病根据病因可分为3类:病因不明的特发性、感染性来源的获得性和由PRNP突变引起的遗传性。监测委员会分析了2494例病例,确定其中1402例为朊病毒病。大多数病例为特发性,即散发性克雅氏病(77%),遗传性和获得性朊病毒病较少(分别为17%和5%)。监测委员会这些年确定的患者数量约为120例,少于朊病毒病的年死亡人数。这种差异部分可能是由于我们的监测需要患者家属同意且并不完整。朊病毒病的平均发病年龄在60多岁后期,范围相当广。脑部磁共振成像以及脑脊液中14-3-3和tau蛋白水平升高具有非常典型的特征。典型的散发性克雅氏病在扩散加权成像(DWI)上可能显示T1加权像(T1WI)完全正常,而大脑皮质和基底神经节有斑片状高信号。在日本,典型的散发性克雅氏病(MM1型)最为常见,但也有一些罕见的非典型亚型。其中,MM2-丘脑型克雅氏病最难诊断,因为除了脑脊液和脑电图特征常常缺失外,其在DWI上也不显示高强度信号。在这种情况下,单光子发射计算机断层扫描(SPECT)显示丘脑的脑血流量减少非常有帮助。日本的遗传性朊病毒病与欧洲的有很大不同。V180I和M232R突变是日本特有的,表现为散发性克雅氏病表型。硬脑膜移植相关克雅氏病(dCJD)中,67%为典型的散发性克雅氏病表型,33%为非典型表型,进展较慢且有淀粉样斑块。追溯实验表明,非典型dCJD的朊病毒蛋白(PrP(sc))可能是由异常VV-2蛋白感染后发生改变而来。尽管如上所述存在一些非典型形式的朊病毒病,但几乎所有朊病毒病例都可通过脑电图、磁共振成像、基因检测、脑脊液检测和SPECT进行诊断。我们也有一些在朊病毒病诊断之前进行脑部手术的事件,还有许多其他患者在针对朊病毒病的手术器械消毒之前就使用了同一器械进行手术。事件委员会开始向患者解释朊病毒病感染的可能性及其后续情况。各国相互合作以攻克这种难治之症非常重要。